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Tetanus disease is one of the most dramatic and globally prevalent
diseases of humans and vertebrate animals, and has been reported
for over 24 centuries. The manifestation of the disease, spastic
paralysis, is caused by the second most poisonous substance
known, the tetanus toxin, with a human lethal dose of 1 ngkg.
Fortunately, this disease is successfully controlled through immu-
nization with tetanus toxoid; nevertheless, according to the World
Health Organization, an estimated 400,000 cases still occur each
year, mainly of neonatal tetanus. The causative agent of tetanus
disease is Clostridium tetani, an anaerobic spore-forming bacte-
rium, whose natural habitat is soil, dust, and intestinal tracts of
various animals. Here we report the complete genome sequence of
toxigenic C. tetani E88, a variant of strain Massachusetts. The
genome consists of a 2,799,250-bp chromosome encoding 2,372
ORFs. The tetanus toxin and a collagenase are encoded on a
74,082-bp plasmid, containing 61 ORFs. Additional virulence-
related factors could be identified, such as an array of surface-
layer and adhesion proteins (35 ORFs), some of them unique to C.
tetani. Comparative genomics with the genomes of Clostridium
perfringens, the causative agent of gas gangrene, and Clostridium
acetobutylicum, a nonpathogenic solvent producer, revealed a
remarkable capacity of C. tetani: The organism can rely on an
extensive sodium ion bioenergetics. Additional candidate genes
involved in the establishment and maintenance of a pathogenic
lifestyle of C. tetani are presented.
Neurotoxigenic clostridia have attracted considerable atten-tion during the past decades. The mode of action of the
strongest toxins known to mankind, the tetanus toxin produced
by Clostridium tetani and the homologous botulinum toxins A–G
produced by various Clostridium botulinum strains, is now well
understood (1–4). The tetanus toxin (TeTx) blocks the release
of neurotransmitters from presynaptic membranes of inhibitory
neurons of the spinal cord and the brainstem of mammals; it
catalyzes the proteolytic cleavage of the synaptic vesicle protein
synaptobrevin (5). This leads to continuous muscle contractions,
which are primarily observed in jaw and neck muscles (lockjaw).
Since the introduction of a potent vaccine during World War II,
cases of tetanus disease have been only sporadic in industrial
countries. However, the disease, and in particular neonatal
tetanus (NT), is still an important cause of death due to
insufficient immunization (4, 6). NT is the second leading cause
of death from vaccine-preventable diseases among children
worldwide. It is considered endemic to 90 developing countries,
with an estimated 248,000 deaths occurring in 1997 (World
Health Organization; www.who.intvaccines-diseasesdiseases
NeonatalTetanus.shtml).
So far, genetic information on C. tetani is mainly restricted to
the nucleotide sequences of the tetanus toxin TeTx and of its
direct transcriptional activator TetR, both of which are encoded
on a plasmid, designated pCL1 in the strain Massachusetts
(7–10). The identification and analysis of all genes in the genome
of C. tetani will contribute to our understanding of the lifestyle
switch from a harmless soil bacterium to a potentially devastat-
ing neurosystem-damaging organism after entering and infecting
a mammalian host. The presented information may also help to
unravel the regulatory network governing tetanus toxin forma-
tion, which is still poorly understood (11).
Methods
Sequencing Strategy. Genomic DNA of C. tetani E88, a nonsporu-
lating variant of strain Massachusetts used in vaccine production,
was extracted and sheared randomly. Several shotgun libraries
were constructed by using size fractions ranging from 1 to 3 kb.
A cosmid library was constructed from TasI partially digested
genomic DNA cloned in the cosmid vector SuperCos1 (Strat-
agene). Insert ends of the recombinant plasmids and cosmids
were sequenced by using dye-terminator chemistry with Mega-
BACE 1000 and ABI Prism 377 DNA automated sequencers
(Amersham Biosciences and Applied Biosystems). Sequences
were processed with PHRED and assembled into contigs by using
the PHRAP assembling tool (12). Sequence editing was done by
using GAP4, which is part of the STADEN package software (13).
A coverage of 9.2-fold was obtained after the assembly of 44,500
sequences. To solve problems with misassembled regions caused
by repetitive sequences and to close remaining sequence gaps,
PCR-based techniques and primer walking on recombinant
plasmids and cosmids were applied.
ORF Prediction and Annotation. Initial ORF prediction was accom-
plished by using the GLIMMER program (www.tigr.orgsoftware
glimmer). The result was verified and improved manually by
using criteria such as the presence of a ribosome-binding site and
codon usage analysis. Annotation was done first automatically by
the ERGO annotation tool (Integrated Genomics, www.inte-
gratedgenomics.com), which was verified and refined by search-
ing derived protein sequences against the public GenBank
European Molecular Biology Laboratory databases by using the
BLAST program (14).
Comparative Genomics. For comparative analysis, each ORF of
C. tetani was searched against all ORFs of Clostridium perfringens
and Clostridium acetobutylicum by using the BLAST program (14).
Significant homology was defined as 30% amino acid identity
over 60% of both the C. tetani protein sequence and the
homologous sequence of C. perfringens or C. acetobutylicum,
respectively.
Results and Discussion
General Features of the C. tetani Genome. The chromosome of
C. tetani contains 2,799,250 bp with a GC content of 28.6%.
The 74,082-bp plasmid pE88 exhibits a remarkably low GC
content of 24.5%. The replication origin of the chromosome was
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identified on the basis of GC-skew analysis, the distinctive
inf lection point in the coding strand and the vicinal presence
of characteristic replication proteins such as DnaA (Fig. 1; also
published as Figs. 5 and 6 in supporting information on the
PNAS web site, www.pnas.org). Eighty-two percent of the
2,368 predicted ORFs on the chromosome are transcribed in
the same direction as DNA replication. A similar figure (83%)
was calculated from the sequence data of C. perfringens (15).
This distinctive codirectionality of replication and transcrip-
tion is not seen in the genomes of pathogens such as Vibrio
cholerae or Yersinia pestis or in archaeal genomes such as
Methanosarcina mazei (17–19). Only a few mobile elements
could be identified in the genome of C. tetani: 16 transposase
genes are present, which can be classified in four different
insertion sequence families. Most of these genes seem to be
nonfunctional because of insertions, deletions, and point
mutations resulting in frame-shifted or degenerated ORFs.
GC variation within the genome is very low; the only regions
with a significantly higher GC content (50%) are those
harboring the six rRNA gene clusters and genes encoding
ribosomal proteins. This lack of GC fluctuation indicates
that recent events of gene acquisition by lateral gene transfer
have not taken place, and that the C. tetani genome is more
stable than the genomes of enteropathogens.
The Tetanus Toxin-Encoding Plasmid pE88. It was known that the
74-kb C. tetani plasmid pE88 harbors the genes for the tetanus
toxin (tetX) and its direct transcriptional regulator TetR (7–10).
We have now identified 61 ORFs, 28 of which show similarities
to known proteins with assigned functions (Fig. 1). Interestingly,
Fig. 1. Circular maps of the chromosome and the plasmid pE88 of C. tetani. The coding sequence of the chromosome is shown in blue or green, depending
on strand orientation. ORFs of C. tetani that have homologous proteins in C. perfringens (15) but not in C. acetobutylicum (16) are shown in orange. ORFs of
C. tetani, which are not present in the two other mentioned clostridial genomes, are shown in pink. The plasmid map shows ORFs color-coded according to their
assigned functions. The gene of the tetanus toxin, tetX (CTP60), and the gene encoding a collagenase, colT (CTP33), are highlighted in red. Numbers at the inner
ring refer to genes mentioned in the text. Most inner rings of both maps show the GC content variation (higher values outward).









pE88 encodes an additional virulence factor, a 114-kDa colla-
genase, designated ColT (CTP33), an enzyme that may play an
important role in C. tetani pathogenesis because of its activity to
destroy tissue integrity in the infected host (20). A multiple se-
quence alignment with other known clostridial collagenases of
Clostridium histolyticum (21), C. perfringens (22) and the one
encoded on the genome of C. botulinum (Sanger Centre, Cam-
bridge, UK, C. botulinum sequencing project), designated ColB,
revealed a different domain structure: ColT lacks segment 2, the
so-called PKD domain of unknown function (Fig. 2). Among
clostridial collagenases, ColT shows the strongest similarity to ColB
of C. botulinum with 79% amino acid identity over segment 1.
Furthermore, nine transport-related genes similar to ATP-
binding cassette (ABC) transporters or associated permeases are
encoded on pE88 as well as eight additional genes coding for
proteins with multiple transmembrane helices. Together, these
proteins are apparently part of five different multisubunit ABC
transporters; most of them show strongest similarity to protein
peptide-transporting systems.
Of special interest for an understanding of the regulatory
network governing the tetanus toxin formation are seven regu-
latory proteins on pE88. Among them is a two-component
system (CTP21CTP22), which shows high similarities to sys-
tems of other Gram-positive bacteria such as Bacillus cereus,
Bacillus halodurans, and C. botulinum. Further regulatory pro-
teins, including TetR, are summarized in Table 1. They show
some similarity to each other, as well as to TxeR from Clostrid-
ium difficile, the alternative -factor regulating the synthesis of
the toxins ToxA and ToxB (23), and to UviA of C. perfringens,
a putative positive regulator of the UV-inducible bacteriocin
gene (24). CTP05 seems to be a pseudogene disrupted by an
authentic frameshift.
The origin of pE88 remains unclear. Over 50% of all ORFs on
pE88 are unique to C. tetani. A mobile element, present in two
copies, shows strongest similarity to a transposase of B. cereus
(60% identity over 355 amino acids). The putative replication
protein of pE88 is duplicated (CTP1 and CTP45). It shows
homology only to a protein (40% identity over 438 amino acids)
encoded on the plasmid of the alkaliphilic Bacillus strain KSM-
KP43 and to the replication protein (39% identity over 418
amino acids) on pIP404, the bacteriocin- and UviA-encoding
10-kb plasmid of C. perfringens CPN50 (25).
Virulence Factors on the Chromosome. In addition to pE88, the C.
tetani chromosome was searched for virulence genes (Table 2).
ORFs for tetanolysin O, hemolysin, and fibronectin-binding
proteins were detected exhibiting homology to ORFs in other
clostridial species including C. perfringens (15, 26). A difference
from C. perfringens is the presence of an array of surface-layer
proteins (SLPs) in C. tetani, all of which are absent in C.
perfringens: 19 homologues of Cwp66, an adhesin of C. difficile,
were found, all of which possess multiple copies of the putative
cell wall-binding domain PF04122 identified in characterized
SLPs (27, 28). Two proteins with multiple leucine-rich repeat
domains similar to Internalin A could be detected, a protein
mediating binding of Listeria monocytogenes to host epithelial
cells (29). In addition, 11 SLP-related ORFs were identified,
which have no homologues in other sequenced clostridial ge-
nomes but contain characterized domains of surface proteins
such as bacterial Ig-like domains (PF02368, PF02369). These
proteins, as well as the Cwp66 homologues, possess a charac-
teristic leader peptide, suggesting that these proteins are ex-
ported. The genes of the SLPs were found to be clustered;
otherwise, pathogenicity islands or mobile elements in flanking
regions of virulence genes could not be detected.
Comparative Genomics. Which other gene products could contribute
to the pathogenic lifestyle of C. tetani? To approach this question,
the genome of C. tetani was compared with the genomes of both C.
perfringens (15), and the nonpathogenic C. acetobutylicum (16) and
homologous ORFs were identified. Focusing on C. tetani, four
groups of ORFs could be distinguished (Fig. 3). Two of them are
of special interest: the 199 ORFs that are common to both C. tetani
and C. perfringens, and the 516 ORFs of C. tetani, which have no
homologues in C. perfringens and C. acetobutylicum (see Tables 3
and 4, which are in supporting information on the PNAS web site,
for the complete ORF lists of these groups). Remarkably, ORFs
encoding 27 peptidases were found within these two groups, many
of them being predicted zinc-metalloproteases. Seven ORFs for
lipid degradation and 15 ORFs for ethanolamine utilization similar
to the eut genes of the genus Salmonella (30) were detected as well
as 21 ORFs for amino acid decomposition, including glutamate
mutase, tryptophanase, histidine ammonia lyase, and lysine-2,3-
aminomutase. The apparent capability of degrading many amino
acids is in contrast to the lack of genes for sugar utilization, which
are abundant in C. acetobutylicum and C. perfringens. Striking is the
Fig. 2. Comparison of clostridial collagenases. Segment comparison of ColG
and ColH of C. histolyticum (21), ColA of C. perfringens (22), ColB of C.
botulinum (Sanger Centre, C. botulinum sequencing project; online access:
ftp:ftp.sanger.ac.ukpubpathogenscb), and ColT of C. tetani. Bacterial
collagenases consist of three different segments (21). Segment 1 represents
the catalytic domain containing the consensus motif for zinc proteases,
HEXXH. Segment 2 contains the so-called PKD domain (PF00801) of unknown
function. The name refers to the polycystic kidney disease protein PKD1, in
which the domain was detected in multiple copies. Segment 3 is thought to be
the collagen-binding domain.
Table 1. Sequence similarities of regulatory elements encoded on pE88 to the characterized regulatory proteins UviA of
C. perfringens, TxeR of C. difficile, and BotRA of C. botulinum
ORF name and size* Annotation UviA (185 aa) TxeR (184 aa) BotRA (178 aa)
CTP5 (172 aa) Frameshift, UviA homolog 32% (48%) 185 aa 31% (49%) 170 aa 26% (43%) 178 aa
CTP10 (179 aa) Putative -factorDNA-binding protein 24% (43%) 184 aa 28% (47%) 82 aa n.s.
CTP11 (184 aa) Putative -factorDNA-binding protein 25% (44%) 180 aa 24% (44%) 179 aa n.s.
TetR (177 aa) Positive regulator of tetX 27% (49%) 183 aa 26% (47%) 184 aa 67% (85%) 177 aa
Percentages indicate identical (in parentheses: similar) amino acids. n.s., not significant.
*Not listed here is the two-component system CTP21CTP22 and CTP4 (71 aa), which shows homology only to UviB (64 aa) of C. perfringens (40% identity over
67 aa).
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presence of 35 genes for sodium ion-dependent systems (Fig. 4).
The primary source for the ion-motive force at the cytoplasmic
membrane of C. tetani is a vacuolar(V)-type ATPase similar to the
ATPase of Enterococcus hirae, which is a Na pump (35). C. tetani
does not harbor the genes of the F0F1-type ATPase; these are
present in C. acetobutylicum and C. perfringens. The lack of the latter
genes in C. tetani is highly exceptional. Therefore, part of the ATP
synthesized in the course of the fermentative metabolism of C.
tetani is hydrolyzed by the V-type ATPase to generate a Na-motive
force at the membrane. This force is used to drive various transport
processes: several sodium-dependent substrate cotransporters are
present, and at least six of the multidrug-resistance exporters seem
to be driven by Na intrusion, whereas there are apparently no
proton-dependent systems present. As a common coupling device
between proton and sodium ion gradients, several HNa anti-
porters were detected, challenging the search for a primary proton
pump: a proton-translocating pyrophosphatase showing similarity
to systems in plant vacuoles is present in C. tetani but absent in other
clostridia. Furthermore, the genes for a membrane-bound electron
transport chain could be identified in the genomes of C. tetani and
C. perfringens. This system shows strong similarity to the
Rhodobacter-specific nitrogen fixation system of Rhodobacter cap-
sulatus as well as to the system NADH:ubiquinone oxidoreductase
found in many aerobic pathogens such as V. cholerae, Salmonella
typhimurium, Y. pestis, and Haemophilus influenzae, in which it
apparently functions as a Na-translocating NADH dehydrogenase
(32, 36). Because there are no reports for quinones in clostridia,
such a NADH dehydrogenase could be involved in the fermenta-
tion of amino acids by C. tetani, as indicated in Fig. 4. A highly active
NADH dehydrogenase was detected in washed membranes of the
closely related Clostridium tetanomorphum (W. Buckel, Philipps-
University, Marburg, Germany, personal communication). This
may be the system that is missing for an understanding of electron
flow from reduced ferredoxin, generated in the pyruvate-
ferredoxin oxidoreductase reaction, via NADH to the NADH-
consuming dehydrogenases of the butyrate pathway.
Protein Secretion. Only little is known about protein secretory
systems in Clostridia. Until now, it has not been understood how
the tetanus toxin, which lacks a typical N-terminal signal peptide,
is exported. The export of toxA and toxB of C. difficile remains
obscure as well, thus the presence of an alternative, so far
unknown mechanism for toxin export was postulated (37).
Because protein secretion is an important part in establishing a
pathogenic phenotype, it is worth having a closer look at
secretory systems and secreted proteins of C. tetani.
Table 2. Virulence-related genes in C. tetani
ORF Product Similar sequences Comment
tetX Tetanus toxin Botulinum toxin (Cb) Unique in C. tetani and Cb
colT Collagenase Cp, Cb, Ba, C. histolyticum Different domain structure of ColT
(Fig. 2)
CTC164, CTC1606 Fibronectin-binding protein Cp, Cb, Cd, Lm, Li, Ba Enables bacteria to colonize wound
tissues and blood clots
CTC594 Putative PAF acetylhydrolase S. pneumoniae, S. mutans, S. pyogenes Inactivates PAF through cleavage of
an acetyl group
CTC586 Hemolysin III Cp, Cb, Ca, Ba, B. cereus Predicted membrane protein with
hemolytic activity
CTC1814 Periplasmic immunogenic protein Ba, Brucella melitensis Outer membrane protein
CTC1855 Myosin-crossreactive antigen Cp, Lm, Li, Cb, S. pyogenes Similar with class II major
histocompatibility antigens
CTC1888 Tetanolysin O Perfringolysin O (Cp), S. pyogenes, Lm Catalyzes the lysis of
cholesterol-containing membranes
CTC2255, CTC2261 Virulence factor MviN Cb, Ca, Cd, Neisseria meningitidis Membrane protein
CTC462, CTC491, CTC504,
CTC515*
SlpACwp66 homologue Cd (29 homologues), Cb (8 homologues) SLP with adhesive properties,
mediates adherence to host tissue




SLP andor adhesion protein — Contain domains found in surface
proteins such as intimin
Ba, B. anthracis; Ca, C. acetobutylicum; Cb, C. botulinum; Cd, C. difficile; Cp, C. perfringens; Li, L. innocua; Lm, L. monocytogenes; S, Streptococcus; PAF,
platelet activating factor.
*Additional ORFs: CTC518, CTC520, CTC521, CTC523, CTC691, CTC696, CTC748, CTC774, CTC775, CTC1202, CTC1364, CTC1872, CTC1980, CTC2092, and CTC2093.
†Additional ORFs: CTC767, CTC769, CTC770, CTC771, CTC772, CTC776, and CTC777.
Fig. 3. Occurrence of homologous ORFs in C. tetani, C. perfringens, and
C. acetobutylicum. Clostridial ‘‘backbone’’ ORFs, white; ORFs in C. tetani with
homologues in C. perfringens but not in C. acetobutylicum, orange; C. tetani
ORFs present in C. acetobutylicum but absent in C. perfringens, red; C. tetani
ORFs not present in C. perfringens and C. acetobutylicum, pink. The size of the
circles is proportional to the number of ORFs in each organism.









A characteristic signal peptide, recognized by the Sec-
dependent secretory mechanism, could be detected in 419
deduced proteins of C. tetani. Of these, 101 proteins are involved
in transport, inclusively periplasmic substrate-binding proteins.
About 160 are conserved proteins of unknown function, most of
them strongly hydrophobic. Virulence and surface proteins,
peptidases, sporulation-specific proteins, as well as sensory
proteins like sensor histidine kinases and chemotaxis proteins
have a predicted N-terminal signal peptide. Thus, the well-
studied prokaryotic Sec-system (38) is apparently the major
protein translocation apparatus in C. tetani. However, not all sec
genes of Escherichia coli and related Gram-negative species are
present in the genomes of C. tetani and other clostridia. SecA,
SecD, SecE, SecF, and SecY could be identified; SecB, a
translocation-specific chaperone and SecG, usually part of the
SecYEG integral membrane complex seems to be missing in the
clostridial group, indicating the existence of a modified Sec-
system. Alternatively, other proteins involved in protein secre-
tion may take over the SecBG functions. A homologue of YajC
(CTG2208) is present, which can form an integral membrane
heterotrimeric complex together with SecD and SecF (39). A
protein in the immediate vicinity of the putative ori (CTG0096)
exhibits some homology to YidC of E. coli, which has recently
been shown to interact with the SecDFyajC complex (39).
Furthermore, CTG166 and CTG458, present exclusively in
clostridia, show homologies to the C-terminal domain of SecA.
In addition, C. tetani possesses genes of a signal-recognition
particle (SRP)-like pathway, a protein translocation system
similar to mammalian SRP. This system is thought to play an
essential role in protein translocation and membrane protein
insertion (40, 41). It consists of the SRP54 homologue Ffh
(CTG1249) and a small cytoplasmic RNA (upstream of
CTG0075), together forming the SRP, which binds to the signal
sequence when it emerges from the ribosomes. FtsY (CTG1246)
is part of the SRP receptor, which is thought to mediate the
reception and insertion of a subset of proteins at the cytoplasmic
membrane. Whether Ffh and FtsY are part of an independent
protein secretion pathway or whether these proteins take over
functions of the Sec-dependent pathway, as proposed previously,
has to be elucidated (42, 43). In C. tetani as well as in all other
sequenced clostridia, there are genes clustered with FtsY and
Ffh, which are putatively involved in the SRP-dependent se-
cretory mechanism: a SRP-associated protein (CTG1247), a
RNA-binding protein (CTG1248), a 16S rRNA processing
protein (CTG1250), a tRNA (Guanine-N1)-methyltransferase
(CTG1251), two ribosomal proteins (L19P and S16P), a signal
peptidase (CTG1253), a GTP-binding protein (CTG1254), and
a ribonuclease (CTG1255).
Fig. 4. Role of Na in amino acid fermentations by C. tetani. The color code is as in Fig. 3. Information on the NADH:ubiquinone oxidoreductaseRhodobacter-
specific nitrogen fixation electron transport system is published as Fig. 7 in supporting information on the PNAS web site. The substrate specificity of many
Na-dependent symporters (tagged with *) remains obscure (31). V-type ATPase, vacuolar-type ATPase; V-type Ppase, vacuolar-type pyrophosphatase; NatAB,
an ATP-binding cassette transporter (32); Fd, ferredoxin; NorM, a Na-translocating multidrug transporter characterized in Vibrio parahaemolyticus (33); SMR,
small multidrug resistance family; NhaC and NhaP, one-subunit secondary HNa antiporters; MRPSHA, this seven-subunit HNa antiporter with similarities
to hydrophobic components of the respiratory Complex I has been characterized in Bacillus subtilis and Staphylococcus aureus (34).
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The Sec-independent TAT (twin arginine translocation) sys-
tem is absent from the C. tetani genome and all clostridial
genomes known so far. Instead, a cluster of 10 genes (CTC1596-
CTC1605) could be identified with similarities to subunits of
type II secretion and type IV pilus biogenesis systems. Two
ORFs (CTC1604, CTC1603) show strong similarities to the
subunits EpsE and F of the type II secretion system in V.
cholerae, which is responsible for the export of the cholera toxin
(44). Three additional ORFs within the C. tetani cluster show
some homology to EpsG, -H, and -I. The other proteins are
hypothetical, occurring only in C. tetani, C. acetobutylicum, and
C. botulinum.
Conclusion
It can be concluded that C. tetani is an invasive anaerobic
pathogen possessing a wide arsenal of virulence factors; this
arsenal is exacerbated by the ability to produce the tetanus toxin
and possibly by the presence of various SLPs of yet unknown
function. The performance of an extensive sodium ion bioener-
getics might be an additional factor for the successful invasion of
infected tissue. The genome sequence of C. tetani now provides
the information on regulatory systems so that the signal trans-
duction pathway leading to tetanus toxin expression can be
studied.
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